Legal and health variations in drug litigation injunctions granted in Minas Gerais

Authors

  • Tiago Lopes Coelho Universidade Federal de Minas Gerais; Faculdade de Medicina
  • Felipe Ferré Universidade Federal de Minas Gerais; Faculdade de Farmácia; Departamento de Farmácia Social
  • Orozimbo Henriques Campos Neto Universidade Federal de Minas Gerais; Faculdade de Medicina
  • Francisco de Assis Acurcio Universidade Federal de Minas Gerais; Faculdade de Farmácia; Departamento de Farmácia Social
  • Mariângela Leal Cherchiglia Universidade Federal de Minas Gerais; Faculdade de Medicina; Departamento de Medicina Preventiva e Social
  • Eli Iola Gurgel Andrade Universidade Federal de Minas Gerais; Faculdade de Medicina; Departamento de Medicina Preventiva e Social

DOI:

https://doi.org/10.1590/S0034-8910.2014048005286

Abstract

OBJECTIVE To investigate the factors related to the granting of preliminary court orders [injunctions] in drug litigations. METHODS A retrospective descriptive study of drug lawsuits in the State of Minas Gerais, Southeastern Brazil, was conducted from October 1999 to 2009. The database consists of 6,112 lawsuits, out of which 6,044 had motions for injunctions and 5,167 included the requisition of drugs. Those with more than one beneficiary were excluded, which totaled 5,072 examined suits. The variables for complete, partial, and suppressed motions were treated as dependent and assessed in relation to those that were independent – lawsuits (year, type, legal representation, defendant, court in which it was filed, adjudication time), drugs (level five of the anatomical therapeutic chemical classification), and diseases (chapter of the International Classification of Diseases). Statistical analyses were performed using the Chi-square test. RESULTS Out of the 5,072 lawsuits with injunctions, 4,184 (82.5%) had the injunctions granted. Granting varied from 95.8% of the total lawsuits in 2004 to 76.9% in 2008. Where there was legal representation, granting exceeded 80.0% and in lawsuits without representation, it did not exceed 66.9%. In public civil actions (89.1%), granting was higher relative to ordinary lawsuits (82.8%) and injunctions (80.1%). Federal courts granted only 68.6% of the injunctions, while the state courts granted 84.8%. Diseases of the digestive system and neoplasms received up to 87.0% in granting, while diseases of the nervous system, mental and behavioral disorders, and diseases of the skin and subcutaneous tissue received granting below 78.6% and showed a high proportion of suspended injunctions (10.9%). Injunctions involving paroxetine, somatropin, and ferrous sulfate drugs were all granted, while less than 54.0% of those involving escitalopram, sodium diclofenac, and nortriptyline were granted. CONCLUSIONS There are significant differences in the granting of injunctions, depending on the procedural and clinical variances. Important trends in the pattern of judicial action were observed, particularly, in the reduced granting [of injunctions] over the period.

Published

2014-10-01

How to Cite

Coelho, T. L., Ferré, F., Campos Neto, O. H., Acurcio, F. de A., Cherchiglia, M. L., & Andrade, E. I. G. (2014). Legal and health variations in drug litigation injunctions granted in Minas Gerais . Revista De Saúde Pública, 48(5), 808-816. https://doi.org/10.1590/S0034-8910.2014048005286

Issue

Section

Original Articles